EU-GMP, FDA&PMDA approved, with CEP APIs, intermediates and contract manufacturing API: Fenbendazole, Flubendazole, Oxfendazole, Cimetidine, Famotidine, Dextromethorphan HBr, Chlophedianol HCl,Apixaban, Linagliptin. http://www.baozong-baoda.com
more >
Year of Establishment:
2006
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Contract Manufacturing,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Service Provider,Manufacturer
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: